NCT00414271View on ClinicalTrials.gov

Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Stage T3-4NxM0 Gastric Cancer
Interventions
DRUG

Docetaxel

Docetaxel 60 mg/m2 IV on day 1

DRUG

Capecitabine

Capecitabine 900 mg/m2 PO two times per day from day 1 to day 14 every 3 weeks for 2 cycles.

Trial Locations (1)

308433

Johns Hopkins Singapore International Medical Center, Singapore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00414271 - Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter